Yuan-Ri Guo

Yuan-Ri Guo

Auto-generated profile, based on publicly available information

Yuan-Ri Guo

Center for Nutraceutical and Pharmaceutical Materials, Myongji University, Yongin, Gyeonggi-do, South Korea

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 November 2015 in Archives of Pharmacal Research
Verified
Journal Article
Closed access
PDF file
SYSun-Myung Yoon
Sun-Myung Yoon
BLBom-Lee Lee
Bom-Lee Lee
YGYuan-Ri Guo
Yuan-Ri Guo
CSChoung Se-Young
Choung Se-Young

1 April 2016 in Journal of Medicinal Food
Verified
Journal Article
Closed access
SKSa-Jic Kim
Sa-Jic Kim
CBChae-Young Bang
Chae-Young Bang
YGYuan-Ri Guo
Yuan-Ri Guo
CSChoung Se-Young
Choung Se-Young
The aim of this study was to investigate the anti-obesity and antihyperlipidemic efficacy and molecular mechanisms of Aster spathulifolius Maxim extract (ASE) in rats with high-fat diet (HFD)-induced obesity. Rats were separately fed a normal diet or a HFD for 8 weeks, then they were treated with ASE (62.5, 125, or 250 mg/kg) for another 4.5 weeks. The ASE supplementation significantly lowered body weight gain, visceral fat pad weights, serum lipid levels, as well as hepatic lipid levels in HFD-induced obese rats. Histological analysis showed that the ASE-treated group showed lowered numbers of lipid droplets and smaller size of adipocytes compared to the HFD group. To understand the mechanism of action of ASE, the expression of genes and proteins involved in obesity were measured in liver and skeletal muscle. The expression of fatty acid oxidation and thermogenesis-related genes (e.g., PPAR-α, ACO, CPT1, UCP2, and UCP3) of HFD-induced obese rats were increased by ASE treatment. On the other hand, ASE treatment resulted in decreased expression of fat intake-related gene ACC2 and lipogenesis-related genes (e.g., SREBP-1c, ACC1, FAS, SCD1, GPATR, AGPAT, and DGAT). Furthermore, ASE treatment increased the level of phosphorylated AMPKα in obese rats. Similarly, the level of phosphorylated ACC, a target protein of AMPKα in ASE groups, was increased by ASE treatment compared with the HFD group. These results suggest that ASE attenuated visceral fat accumulation and improved hyperlipidemia in HFD-induced obese rats by increasing lipid metabolism through the regulation of AMPK activity and the expression of genes and proteins involved in lipolysis and lipogenesis.

1 December 2021 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
PNPhuong Nguyen
Phuong Nguyen
KKKee-Young Kim
Kee-Young Kim
AKA-Young Kim
A-Young Kim
SKSangKook Kang
SangKook Kang
AOAngelica F. Osabutey
Angelica F. Osabutey
YKyoung koh
young koh

17 May 2021 in Journal of Medicinal Food
Verified
Journal Article
Closed access
YGYuan-Ri Guo
Yuan-Ri Guo
HJHui Jin
Hui Jin
MKMinsang Kim
Minsang Kim
MSMyeong Bae Shin
Myeong Bae Shin
JLJu Hyeong Lee
Ju Hyeong Lee
JSJoo-Won Suh
Joo-Won Suh
We previously reported that mature Bombyx mori silkworm (SW) ameliorated scopolamine (Sco)-induced amnesia, and Angelica gigas (AG) prevented cognitive impairment. SW is known for its gastroprotective effects such as improving liver function and alleviating the effects of Parkinson's disease. AG is known for its neuroprotective effects and for lowering the effects of low-density lipoprotein cholesterol. However, the neuroprotective effect of combined SW and AG (SWA-1) treatment and the underlying molecular mechanism by which SWA-1 regulates neurodegenerative diseases remains unclear. We evaluated the neuroprotective effect of SWA-1 against Sco-induced mild cognitive impairment in mice and H 2 O 2 -induced cell death in HT22 mouse hippocampal neuronal cells and elucidated the underlying molecular mechanism. Morris water maze and Y-maze tests were performed to examine the learning and memory abilities of mice. The underlying molecular mechanism was investigated by using western blotting. We demonstrated that SWA-1 significantly protects against H 2 O 2 -induced cell death in HT22 mouse hippocampal neuronal cells. SWA-1 also significantly reversed Sco-induced spatial learning and memory impairment. Specifically, SWA-1 upregulates the protein levels of phosphorylated extracellular signal-related kinase (Erk1/2) and phosphorylated p38 MAP kinase (p38). SWA-1 remarkably decreased the apoptotic index Bax/Bcl2 expression in the hippocampus of Sco-treated mice. Our results suggest that SWA-1 may be administered as alternative therapy for cognitive impairment and neurodegenerative diseases and should be studied further in human trials.